Acalabrutinib M45 Metabolite
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

Acalabrutinib M45 Metabolite

● 재고 있음

카탈로그 번호:VE0024685
CAS 번호:N/A
분자식:C26H27N7O3
분자량:485.5 g/mol

에 대한 추가 정보 Acalabrutinib M45 Metabolite

모약물

Acalabrutinib

IUPAC명

4-(8-Amino-3-((2S)-1-(3-hydroxybutanoyl)pyrrolidin-2-yl)imidazo[1, 5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

약전 동의어

N/A

Other Synonyms

N/A

SMILES

O=C(NC1=NC=CC=C1)C2=CC=C(C3=C4C(N)=NC=CN4C([C@H]5N(C(CC(O)C)=O)CCC5)=N3)C=C2

InChI

InChI=1S/C26H27N7O3/c1-16(34)15-21(35)32-13-4-5-19(32)25-31-22(23-24(27)29-12-14-33(23)25)17-7-9-18(10-8-17)26(36)30-20-6-2-3-11-28-20/h2-3, 6-12, 14, 16, 19, 34H, 4-5, 13, 15H2, 1H3, (H2, 27, 29)(H, 28, 30, 36)/t16?, 19-/m0/s1

설명

The Acalabrutinib M45 Metabolite standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Acalabrutinib. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url